Medindia

X

Latest drug shows promise in multiple myeloma

by Medindia Content Team on  December 19, 2002 at 6:03 PM General Health News   - G J E 4
Latest drug shows promise in multiple myeloma
According to researchers, many trials show that a new type of drug can assist patients with multiple myeloma who have failed to respond to other treatments. Multiple myeloma is an incurable cancer of the bone marrow. Researchers at Dana-Farber Cancer Institute have been assessing a new drug, called bortezomib, in a group of 180 patients who had not been helped by other forms of treatment. In the first sub-group, consisting of 65 patients, 30 per cent showed at least a partial response, with some showing a complete response, in which no sign of active disease could be detected.
Advertisement

In all, 78 per cent either had their condition either stabilize or improve from the start of the therapy, and some were still showing a positive response up to a year later. Bortezomib is a new kind of drug called a proteasome inhibitor. It acts on tiny structures called proteasomes within cells and so stops myeloma cells from multiplying.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All